A model-based approach to optimize detection of treatment effects in early oncology trials. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM) ...